|Articles|April 13, 2016
Implications of Mid-Study Clinical Trial Protocol Changes
Advertisement
Medidata & Tufts Center for the Study of Drug Development announced results of a study on the impact of protocol amendmends made while a clinical trial is underway. The study discussed their avoidability, costs and time delays.
Read the full release
Read more in Kenneth Getz’s column this month
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
2
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
3
Breaking the Efficacy Ceiling in IBD and Beyond
4
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
5